Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
June 14, 2011
Patent Application Number
12619357
Date Filed
November 16, 2009
Patent Primary Examiner
Patent abstract
The present invention relates to recombinant lipidated PsaA proteins and recombinant constructs from which such lipidated PsaA proteins may be expressed. The invention relates further to lipidated PsaA proteins in which lipidation is effected by the use of a heterologous leader sequence derived from the ospA gene of Borrelia burgdorferi, which leader sequence is joined in translational reading frame with the psaA structural gene. The invention also provides methods of preparation of lipidated PsaA proteins and use of such proteins in immunological compositions. Also provided are vaccines comprising immunogenic lipidated PsaA proteins and methods of use of such vaccines in the prevention and treatment of S. pneumoniae infection.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
